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Carbon dots exhibit great potential in applications such as molecular imaging and in vivo molecular tracking. However,
how to enhance fluorescence intensity of carbon dots has become a great challenge. Herein, we report for the first time
a new strategy to synthesize fluorescent carbon dots (C-dots) with high quantum yields by using ribonuclease A (RNase
A) as a biomolecular templating agent under microwave irradiation. The synthesized RNase A-conjugated carbon dots
(RNase A@C-dots) exhibited quantum yields of 24.20%. The fluorescent color of the RNase A@C-dots can easily be
adjusted by varying the microwave reaction time and microwave power. Moreover, the emission wavelength and intensity
of RNase A@C-dots displayed a marked excitation wavelength-dependent character. As the excitation wavelength alters
from 300 to 500 nm, the photoluminescence (PL) peak exhibits gradually redshifts from 450 to 550 nm, and the intensity
reaches its maximum at an excitation wavelength of 380 nm. Its Stokes shift is about 80 nm. Notably, the PL intensity is
gradually decreasing as the pH increases, almost linearly dependent, and it reaches the maximum at a pH = 2 condition;
the emission peaks also show clearly a redshift, which may be caused by the high activity and perfective dispersion of
RNase A in a lower pH solution. In high pH solution, RNase A tends to form RNase A warped carbon dot nanoclusters.
Cell imaging confirmed that the RNase A@C-dots could enter into the cytoplasm through cell endocytosis. 3D confocal
imaging and transmission electron microscopy observation confirmed partial RNase A@C-dots located inside the
nucleus. MTT and real-time cell electronic sensing (RT-CES) analysis showed that the RNase A@C-dots could effectively
inhibit the growth of MGC-803 cells. Intra-tumor injection test of RNase A@C-dots showed that RNase A@C-dots could
be used for imaging in vivo gastric cancer cells. In conclusion, the as-prepared RNase A@C-dots are suitable for
simultaneous therapy and in vivo fluorescence imaging of nude mice loaded with gastric cancer or other tumors.
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Carbon dots (C-dots) are a new member of the carbon
nanomaterial family after C60, carbon nanotubes, and
graphene and were firstly discovered by accident when
researchers were trying to purify single-walled carbon
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in any medium, provided the original work is p[1]. Since then, many studies concerning C-dots have
been reported [2-4]. C-dots have attracted much attention
due to their well-defined, nearly isotropic shapes together
with their ultrafine dimensions and tunable surface
functionalities. Moreover, a variety of simple, fast, and
cheap synthetic routes for C-dots have been developed
in the past few years including arc discharge, laser ab-
lation, electrochemical oxidation, hydrothermal, com-
bustion/thermal, supported synthetic, and microwave
methods [4-6]. Most notable superiority, however, is their
potential as replacements for toxic heavy metal-based
quantum dots (QDs) which are currently intensively
used and are plagued by safety concerns and known
environmental hazards [2,5,6].pen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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with photoluminescence properties comparable and even
superior to those of QDs [2,3,7], such as high photo-
stability, tunable emission, large two-photon excitation
cross section [8,9], and non-blinking fluorescence [10].
C-dots have been successfully applied in bioimaging
[11], both in vitro [8] and in vivo [12], and even showed
significant utility in multiphoton imaging [9]. Moreover,
beyond these apparently straightforward applications,
more complicated designs aimed at multifunctional nano-
systems based on C-dots have been reported. For example,
Huang and his collaborators [13] have developed a new
theranostic platform based on photosensitizer-conjugated
carbon dots with excellent imaging and tumor-homing
ability for NIR fluorescence imaging-guided photodynamic
therapy. Moreover, a C-dot-based inorganic-organic nano-
system for two-photon imaging and biosensing of pH
variation in living cells and tissues has also been designed
by Kong's research group [14]. Almost during the same
period, C-dots with PEI (polyetherimid)-passivation were
used for bioimaging and as nanocarrier for gene delivery
[15]. However, with the rapid progress of research and
application, many defects were thoroughly exposed
such as low photoluminescence intensity, short wave-
length excitation, and difficulties in separation and purifi-
cation, which did hinder it to further in vitro or in vivo
biological applications.
Previously, preparation of surfaced-functionalized C-dots
usually included three steps: synthesis of raw C-dots,
passivation operations, and functionalization reactions
[16]. Most C-dots prepared, if without further compli-
cated purification, passivation, and functionality, featured
quite low quantum yield (around or less than 5%)
[1,17-22] and retained very limited application potentials.
So it is extremely necessary to find a simply strategy to
fabricate surface-functionalized C-dots with relatively high
quantum efficiency.
As to the preparation methods, they could be divided
into two categories: top-down methods and bottom-up
methods. The bottom-up methods usually suffer from
complex processes, or expensive starting materials and
severe synthetic conditions, which are unlikely to be ex-
tended significantly in the near future [23]. Alternatively,
bottom-up synthetic approaches based on chemistry
have been desired to achieve C-dots with fluorescence.
Presently, Li et al. reported a facile hydrothermal method
to prepare luminescent carbon dots (L-CDs) with high
quantum yield value (44.7%) and controllable emission
wavelengths and used prepared carbon dots to detect toxic
Be2+ ions [6].
To date, microwave pyrolysis approach, as one family
member of bottom-up synthesis methods, has been
developed and widely used for its simplicity, cost/time-
efficiency, environmental friendliness, easiness to scaleup, and more importantly convenience to realize synthesis,
passivation, and functionalization reactions simultaneously
through only one synthesis step [4,24].
Herein, we report for the first time a green synthesis
route, only one synthesis step followed by limited and
simple purification, without further passivation and sur-
face functionality to prepare ribonuclease A-conjugated
C-dot nanoclusters (RNase A@C-dots). It is well known
that RNase A is a low molecular weight protein (approxi-
mately 124 residues, approximately 13.7 kDa, pI = 9.4)
with a globular conformation (2.2 nm× 2.8 nm× 3.2 nm)
[25]. The protein has proved to be thermally stable [26],
even under microwave heating for a couple of minutes
[27]. In addition, RNase A has been confirmed to be able
to inhibit the growth of cancer cells as a result of its en-
zymatic activity of degrading cellular RNA and has been
proven to be effective in clinical trials as a chemothera-
peutic agent [28,29]. In our previous work, we used
RNase A as a biomolecular templating agent to synthesize
CdTe QD nanoclusters [27]. Meanwhile, through chemical
bonding of the targeting RGD peptide on the RNase
A@CdTe QD cluster surface, we constructed multifunc-
tional biological nanoprobes which shows the efficiency of
the nanosystem for synchronous in vitro targeted cancer
imaging and therapy [27]. Inspired by the achievements of
previous studies and concerned with the shortcomings
along with the accomplishments, we proposed the synthe-
sis of RNase A@C-dots via a one-step microwave-assisted
method using citric acid as carbon precursor and RNase A
as an assisting agent. The method greatly simplified the
synthesis processes, conveniently realized the improve-
ment of the photoluminescence intensity, and largely
retained the activity of RNase A for potential therapeutic
applications. Prepared RNase A@C-dots exhibited multi-
functional properties and were successfully employed for
tumor fluorescence imaging and therapy.
Methods
Materials
Bovine pancreatic ribonuclease A (RNase A) and poly-
ethylene glycol (PEG2000N) were purchased from Sigma-
Aldrich Chemical Co. (St. Louis, MO, USA). Citric acid
(CA, analytical grade) was bought from Shanghai Chem-
ical Reagent Co., Ltd. (Shanghai, China). 3-[4,5-Dimethyl-
thiazol-2yl]-2,5-diphenylterazolium bromide (MTT) was
obtained from Invitrogen Corporation (Carlsbad, CA,
USA). MGC-803 cell lines were obtained from the Cell
Bank of Type Culture Collection of Chinese Academy of
Sciences. Cell culture products and reagents, unless
pointed out, were all purchased from Gibco (Invitrogen
Corporation, Carlsbad, CA, USA). All chemical reagents
were used without further purification. All solutions were
made with purified water (with a low electroconductivity
of 18.2 MΩ cm).
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(C-dot surface modified by PEG2000N)
For the synthesis of RNase A@C-dots, 2 g citric acid and
0.15 g RNase A were diluted in 10 ml water within a
25-ml glass bottle and put under ultrasonic for 1 to
2 min to form a uniform solution. Then, the transparent
solution was put into a domestic microwave oven (700 W)
for 3 to 5 min. After cooling to room temperature, the
obtained brown C-dot solution was dialyzed against pure
water with a dialysis membrane (molecular weight cutoff
(MWCO) of 1,000) for 2 days to remove unreacted citric
acid. Finally, the dry C-dot composite was freeze-dried in
vacuum, weighed, and dissolved in ultrapure water with a
fixed concentration.
In control experiments, citric acid without RNase A
was treated with the same procedure and the final
product was named C-dots. Then, to modify the surface
of C-dots with PEG2000N, the mixture solution of C-dots
and PEG2000N (mass ratio, C-dots/PEG2000N =1:20) was
refluxed with nitrogen gas protection at 120°C for 72 h.
Then, the mixture was shifted into a dialysis membrane
(MWCO of 3,000) against pure water to remove surplus
PEG2000N.
Characterization
To determine the size and morphology, RNase A@C-dots
were characterized by high-resolution transmission elec-
tron microscopy (HR-TEM, JEM-2100 F, 200 kV, JEOL
Ltd., Tokyo, Japan). The samples for TEM/HR-TEM were
made by simply dropping aqueous solution of the C-dots
onto a 300-mesh copper grid casted with a carbon film.
UV–Vis absorption spectra of the C-dots were measured
with a Varian Cary 50 spectrophotometer (Varian Inc.,
Palo Alto, CA, USA). Fluorescence excitation and
emission spectra of RNase A@C-dots were recorded
on a Hitachi FL-4600 spectrofluorimeter (Hitachi Ltd.,
Tokyo, Japan). Zeta potential of RNase A@C-dots was
measured on a Nicomp 380 ZLS zeta potential/particle
sizer (PSS. Nicomp, Santa Barbara, CA, USA). X-ray
photoelectron spectroscopy (XPS) was obtained at
room temperature by a Kratos Axis Ultra spectrometer
(AXIS-Ultra DLD, Kratos Analytical Ltd., Tokyo,
Japan) using a monochromated Al Kα (1486.6 eV) source
at 15 kV. Fourier transform infrared (FTIR) spectra
were obtained on a Nicolet 6700 spectrometer (Thermo
Electron Corporation, Madison, WI, USA). The samples
for FTIR measurement were prepared by grinding the
dried C-dots with KBr together and then compressed into
thin pellets. X-ray diffraction (XRD) profiles of the C-dot
powders were recorded on a D/MAX 2600 PC (Rigaku,
Tokyo, Japan) equipped with graphite monochromatized
Cu Kα (λ = 0.15405 nm) radiation at a scanning speed
of 4°/min in the range from 10° to 60°. Time-resolved
fluorescence intensity decay of RNase A@C-dots wasperformed on a LifeSpec II (Lifetime only, Edinburgh
Instruments, Livingston, UK). The sample was excited
by 380-nm laser, and the decay was measured in a time
scale of 0.024410 ns/channel.
Quantum yield measurement
To assess the quantum yield of RNase A@C-dots, quinine
sulfate in 0.1 M H2SO4 (quantum yield, 54%) was used as
a reference fluorescence reagent. The final results were
calculated according to Equation 1 below:








where Φstd is the known quantum yield of the stand-
ard compound, Fsample and Fstd stand for the integrated
fluorescence intensity of the sample and the standard
compound in the emission region from 380 to 700 nm,
Astd and Asample are the absorbance of the standard com-
pound and the sample at the excitation wavelength
(360 nm), and n is the refractive index of solvent (for
water, the refractive index is 1.33).
To minimize the reabsorption effects, UV absorbance
intensities of the samples and standard compound should
never exceed 0.1 at the excitation wavelength. Photolumi-
nescence (PL) emission spectra of all the sample solutions
were measured at the excitation wavelength of 360 nm.
The integrated fluorescence intensity is the area under the
PL curve in the wavelength from 380 to 700 nm.
Cell culture, cell viability assay, and time-dependent cell
response profiling
The human gastric cancer cell line MGC-803 cell
was maintained at 37°C (5% CO2) in Dulbecco's modi-
fied Eagle's medium (DMEM, HyClone, Thermo Fisher
Scientific, Waltham, MA, USA) supplemented with 10%
(v/v) fetal bovine serum (Gibco), 100 U/ml penicillin, and
1 mg/ml streptomycin.
For MTT assay, MGC-803 cells were seeded in a
96-well plate (Corning Costar, Corning, NY, USA) with
a density of 5 × 103 cells/well with 10% fetal bovine
serum and then cultured overnight. After culturing,
those cells were incubated with C-dots of various con-
centrations for 24 h. Following the incubation, the super-
natant was removed and the cells were washed once with
0.01 M PBS. Then 150 μl DMEM and 15 μl MTT stock
solution (5 mg/ml in PBS, pH 7.4) were added to each
well, and after this, the cells were allowed to incubate for
4 h at 37°C. Finally, after removing the culture medium,
150 μl DMSO was added to dissolve the Formosan crys-
tals. The optical density (OD) was measured at 570 nm
on a standard microplate reader (Scientific Multiskan
MK3, Thermo Fisher Scientific, Waltham, MA, USA).
The cell viability was calculated according to the following
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OD of the control group) × 100%. The cell viability of
control groups was denoted as 100%.
The time-dependent cell response profiles were per-
formed using a real-time cell electronic sensing (RT-CES)
system. Firstly, 100 μl of media was added to 16-well
E-plates to record background readings, and then, 100 μl
of cell suspension (containing about 5,000 cells) was
added. Secondly, the cells in the E-plates were allowed to
incubate at room temperature for 30 min. After the incu-
bation, the E-plates were put on the reader in the incuba-
tor to continuously record the electric impedance which
is reflected by cell index. After 20 to 24 h, the RNase
A@C-dots and C-dots of certain concentration were
added into the E-plates to mix with cells. For compari-
son, each plate also contained wells added with RNase A
and wells with cells alone in the media in addition to
media-only wells. The cells were monitored every 2 min
for the first 1 h after the addition of C-dots and RNase A
to get the short-term response and for every 30 min from
1 h after C-dot addition to about 48 h to record the
long-term response.
Laser scanning confocal microscopy imaging in vitro
For fluorescence imaging with RNase A@C-dots, MGC-
803 cells were first plated on 14-mm glass coverslips and
allowed to adhere for 24 h at 37°C. Second, the cells
were co-incubated with 120 μM RNase A@C-dots for
24 h. Then, the cells were washed with phosphate buff-
ered (PBS) solution to remove unbound nanoparticles.
Finally, the cells were fixed with 4% paraformaldehyde,
and the nuclei of the cells were stained with 4′,6-diami-
dino-2-phenylindole (DAPI) (0.5 mg/ml in PBS).
Confocal fluorescence 2D or 3D imaging was performed
on a TCS SP5 confocal laser scanning microscope (Leica
Microsystems, Mannheim, Germany) with an objective
lens (×63). In our experiment, we used a 408-nm excita-
tion wavelength laser. Optical sections were averaged
three times to reduce noise.
RNase A@C-dots for in vivo fluorescence imaging
Male 4-week-old athymic nude mice were purchased
from Shanghai Slac Laboratory Animal Co. Ltd (Shanghai,
China). All experiments that involve animal use were per-
formed in compliance with the relevant laws and institu-
tional guidelines. All animal experiments were approved
by the Institutional Animal Care and Use Committee of
Shanghai Jiao Tong University (No. SYXK2007-0025). For
the establishment of the tumor model, MGC-803 cells
were resuspended in PBS, and 2 × 106 cells per site were
subcutaneously injected. The tumor nodules had reached
a volume of 0.1 to 0.3 cm3 approximately 3 weeks post-
injection. For in vivo fluorescence tumor imaging experi-
ments, 100 μl (5 mg/ml) RNase A@C-dot aqueous solutionwas intratumorally injected into the MGC-803 tumor-
bearing mice. Time-course fluorescent images (excitation,
500/20 nm; emission, 600/30 nm; integration time, 5 s)
were acquired on a Bruker In-Vivo F PRO imaging system
(Bruker, Billerica, MA, USA).
Results and discussion
Characterization and properties of RNase A@C-dots
TEM images of the as-prepared RNase A@C-dots that
were trapped in the dialysis membrane (MW cutoff 1,000)
are shown in Figure 1a; the size of the RNase A@C-dots
varies mainly within 25 to 45 nm with relatively irregular
morphologies. High-resolution TEM image (Figure 1b,
the zoomed-in image of the area within the circle in
Figure 1a) clearly shows that the particles are actually
formed by encapsulating several C-dots within the RNase
A film, so we can call them clusters. The clusters can also
extremely easily disperse in pure water. In Figure 1c,
the average size of C-dot that dispersed out of the dialysis
membrane is about 4 nm (Figure 1f ) in diameter with
nice spherical morphologies (Figure 1d), and the disper-
sions are also excellent. Lattice spacing of approximately
0.23 nm clearly displayed in the high-resolution TEM
image (Figure 1d) indicates the (100) facet of graphite [30].
We can reasonably conclude that during the reaction
process accelerated by microwave heating, RNase A
capped the different numbers of C-dots that cause the
different sizes of particles. When dialyzing against pure
water, the smaller single particles diffused out of the
dialysis membrane (MW cutoff 1,000), while the larger
sized clusters remained inside the membrane. So we can
collect two kinds of the relative uniform particles. In our
experiments, we use the RNase A@C-dot clusters that
are retained in the dialysis membrane except for special
description.
As shown in Figure 1e, the XRD pattern of the RNase
A@C-dot clusters has two distinctly sharp peaks at 2θ of
approximately 27° (d = 0.33 nm) and approximately 39°
(d = 0.23 nm) which can be attributed to (002) and (100)
facets of graphite [30]. Notably, there is a broad peak at
2θ of around 20° (d = 0.42 nm) which is probably the re-
flection of the (002) facet of graphite; however, the larger
interlayer spacing of 0.42 nm compared to that of bulk
graphite which is about 0.33 nm might have resulted
from the poor crystallization [31].
The UV–Vis absorption spectra (Figure 2a, black line)
of the RNase A@C-dots feature a typical absorbance of
C-dots which shows strong optical absorption in the UV
region with a tail extending out into the visible range
[8]. On the other hand, the absorbance peak of the pure
RNase A is at approximately 275 nm as shown in Figure 2a
(red line). Compared with UV–Vis absorbance peaks of
C-dots (prepared by microwave synthesis using citric acid
as a carbon precursor without RNase A) and the pure
Figure 1 TEM and HR-TEM images, XRD pattern, and size distribution of RNase A@C-dots. (a) TEM image of the as-prepared RNase A@C-dots
inside the dialysis membrane after dialyzing against pure water. One typical RNase A@C-dot cluster is labeled with a black circle. (b) High-resolution
TEM (HR-TEM) image of one focused area within the black circle. (c) TEM image of the C-dots outside the dialysis membrane. (d) HR-TEM image of one
single C-dot. (e) XRD pattern of RNase A@C-dots. (f) Size distribution of C-dots.
Figure 2 UV–Vis absorption and PL spectra and fluorescence decay profile of RNase A@C-dots. (a) UV–Vis absorption of the as-prepared
RNase A@C-dots (black line) and RNase A treated by microwave for 4 min (red line). (b) PL spectra of the as-prepared RNase A@C-dots at excitation
from 300 to 500 nm in 20-nm increment. Inset: image of the as-prepared RNase A@C-dot dispersion under visible light (left) and UV light (right).
(c) Fluorescence decay profile (λex = 380 nm, λem = 450 nm) of the as-prepared RNase A@C-dots. (d) The effect of the solution pH value over the
fluorescence (λex = 360 nm) of the as-prepared RNase A@C-dots.
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tion spectra. First, the absorbance peak of the C-dots
(Additional file 1: Figure S2a) is at approximately 240 nm
which has resulted from π-π* transition [32], while in the
absorbance spectrum of RNase A@C-dots (Figure 2a,
black line), the peak shifts to approximately 260 nm which
may be caused by the increasing size of RNase A@C-dots
as a cluster and the synergy of RNase A and C-dots. In the
TEM image of C-dots, it has shown clearly that the RNase
A@C-dots are actually clusters with several C-dots capped
by RNase A films. The RNase A itself did not distinctly
change its UV–Vis absorption character before and after
microwave treatment for 4 min (see Additional file 1:
Figure S1). Second, there is a noticeable absorbance in-
crease of RNase A@C-dots from 300 to 450 nm compared
to that of C-dots which is very likely to benefit from the
surface passivation by RNase A [24].
Dramatic changes have been reflected in their PL prop-
erties. The PL spectrum of RNase A@C-dots (Figure 2b)
shows a clear λex dependence of both emission wavelength
and intensity just as we have reported before [8]. Specific-
ally, as the excitation wavelength changes from 300 to
500 nm in a 20-nm increment, the PL peak shifted from
450 to 550 nm, while the intensity increases before the ex-
citation wavelength reaches 380 nm and then gradually
decreases followed by increase of excitation wavelength.
However, in the PL spectra of C-dots (Additional file 1:
Figure S2b), we cannot find that there is no a typical λex
dependence character. When the excitation wavelength
changes from 280 to 440 nm, the PL intensity at around
480 nm varies and hits its maximum at an excitation
wavelength of 380 nm. But the emission wavelength does
not change its location. Moreover, before the excitation
wavelength reaches 380 nm, there is more than one emis-
sion peak in the PL spectra with only one peak around
480 nm remaining when excited at 390 nm and longer
wavelength. Furthermore, photoluminescence excitation
(PLE) spectra of RNase A@C-dots (Figure 2b) have only
one peak located at around 390 nm, while the PLE spectra
of C-dots (Additional file 1: Figure S2b) owns two with an
additional one around 290 nm.
The existence of RNase A has not only changed the
features and locations of PL spectra but also enhanced
the intensity of photoluminescence. When excited at
360 nm, the intensity of RNase A@C-dots is about 30
times the intensity of C-dots (Additional file 1: Figure
S2c). As to quantum yield, Table 1 shows that theTable 1 Related photoluminescent quantum yield (PLQY)
of RNase A@C-dots, C-dots, and C-dots-PEG2000 (C-dots
passivated by PEG2000)
Sample RNase A@C-dots C-dots C-dots-PEG2000
PLQY [%] 24.20 0.87 4.33quantum yield of the RNase A@C-dots is 24.20%
which is dramatically higher than the 0.87% yield of
C-dots. Even after having been passivated with PEG2000
which is widely accepted as an efficient way to improve
the quantum yield of C-dots [8], the quantum yield of
C-dots is 4.33%, still much lower than that of the
RNase A@C-dots.
Luminescence decay (Figure 2c) has an average excited-
state lifetime of 3.3 ns for emission at 450 nm with an
excitation wavelength of 380 nm which is comparable to
those reported [2,23]. The relatively short lifetime might
as well suggest the radioactive recombination of the
excitation contributing to the fluorescence [23].
The FTIR spectrum (Figure 3d) shows the presence
of (C = O) (1,719 cm−1), (O-H) (3,425 cm−1), (C-N)
(1,209 cm−1), and (N-H) (2,994 cm−1) which directly
indicates Rnase A coated C-dot surface. This can also
be confirmed by the X-ray photoelectron spectroscopy
(XPS) of RNase A@C-dots (as shown in Figure 3a,b,c).
Moreover, the high-resolution N 1 s spectrum of the
RNase A@C-dots (Figure 3c) has clear signs of both amide
N (399.3 eV, C-N) and doping N (400.4 eV, O =C-NH-)
atoms. The XPS (Additional file 1: Figure S3) of the C-dots
only shows the signals of -COOH and -OH, and neither
amide N nor doping N is detected. So we may speculate
that the RNase A might have played double roles in the
microwave-assisted synthesis process: N doping and sur-
face passivation. They are responsible for the enhanced PL
intensity of RNase A@C-dots [33].
The average zeta potential of C-dots (Figure 3e) is
0.02 mV, slightly beyond zero. Considering the fact that
cells are with positive charges, a zeta potential of no less
than zero is definitely favorable in cell labeling and imaging.
(The influence of microwave condition on PL of carbon
dots was also investigated, as shown in Additional file 1:
Figure S5).
Effects of pH on PL properties of RNase A@C-dots
Although the mechanism of PL properties of C-dots is
still unclear and debatable, there is solid evidence of
lower quantum efficiency of C-dots that is caused by the
fast recombination of excitations located at surface en-
ergy traps [8]. Therefore, after modifying the surface of
C-dots using different surface passivation reagents, the
PL properties of the C-dots can be significantly improved
[7,8,34]. In this work, we firstly introduce the bioactive
enzyme RNase A to synthesize C-dots by one-step
micro-assisted synthesis method. The mechanism of the
PL enhancement could be explained by following two
reasons: Firstly, we propose that the electron-donating
effect which resulted from the abundant amino acid
groups on the surface of RNase A, especially those
amino acids with benzene rings, might contribute a lot
to the much enhanced PL intensity of the C-dots. To
Figure 3 XPS and FTIR spectra and zeta potential. (a) XPS C 1 s spectrum. (b) XPS O 1 s spectrum. (c) XPS N 1 s of RNase A@C-dots. (d) FTIR
spectra of RNase A@C-dots. (e) Zeta potential of RNase A@C-dots.
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lanine as replacements of RNase A to synthesize C-dots
in the same conditions. As shown in Additional file 1:
Figure S5b, both tryptophan and thenylalanine can
greatly enhance the PL intensity. Secondly, we think
that in the microware heating reaction, RNase A acts as
a N doping reagent that causes the PL enhancement of
the C-dots. The data of IR and XPS can also support the
point.
In the biological application, pH is a very important
factor that we firstly take into consideration. Herein, the
influence of pH values over the PL of the RNase A@C-
dot clusters is indicated in Figure 2d. The fact that pH
values could affect the PL intensity has been seen in
quite a few studies [10,21,32,35]. Generally, PL intensity
reaches its maximum at a certain pH values, 4.5 [35] or
7 [21]. At the same time, a slight redshift in the emission
peak was identified with the increase of pH value [35].
Interestingly, the pH value played a unique role upon
the PL of RNase A@C-dots. There was a noticeable red-
shift in the emission peak when the pH went from 2.98
to 11.36. However, the PL intensity decreases continu-
ously as pH values increase. Specifically, the C-dots lost
about 25% of its PL intensity when the pH increases
from 2.98 to 7.32 and retain only 40% of its intensitywhen the pH value comes to 11.36. We speculate that at
the lower pH condition, the RNase A coating on the
surface of C-dots keeps a high activity and the RNase
A-modified C-dots remain monodispersed in the water
solution. Although the underlying origin is still vague,
the fact that the C-dots keep its PL intensity at a rela-
tively high level, going through the pH value from very
acidic to neutral, shows promising advantages in biological
applications.
Laser scanning confocal microscopy imaging in vitro
Figure 4 shows the 2D images of MGC-803 cells labeled
with RNase A@C-dots. After co-incubation with RNase
A@C-dots, MGC-803 cells show bright green color over
the entire cell upon excitation at 405 nm. The nuclei
marked by PI, when excited at 536 nm, featured strong
red fluorescence. A merge image clearly shows that the
RNase A@C-dots can enter the cell via the endocytic
route. Moreover, we can also find that in up to 10% cells,
there are clearly green dots existing in the nucleus.
Meanwhile, a 3D confocal imaging (Figure 5) of the cell
clearly reveals that the RNase A@C-dots have entered
the cell, while the carbon dots reported before [7] were
mostly in the cytoplasm and membrane, with only minor
penetration into the cell nucleus. Until now, we can give
Figure 4 Laser scanning confocal microscopy images of MGC-803 cells. (a) Picture of MGC-803 cells under white light. (b) Picture of MGC-803
cells under excitation at 405 nm. (c) Picture of MGC-803 cells under excitation at 536 nm. (d) Overlapping picture of MGC-803 cells under excitation at
405 and 536 nm. (e) Amplified picture of a single MGC-803 cell under white light. (f) Amplified picture of a single MGC-803 cell under excitation at
405 nm. (g) Amplified picture of a single MGC-803 cell under excitation at 536 nm. (h) Overlapping picture of a single MGC-803 cell under excitation
at 405 and 536 nm.
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may be caused by the small size of RNase A@C-dots
which enables perfect dispersion or assists protein (derived
from RNase A) action.
Cytotoxicity assay by MTT and real-time cell electronic
sensing
To test the potential of the RNase A@C-dots in cancer
therapy, MTT assay was used to determine the cytotoxicity
profile. The different concentrations of RNase A@C-dots
were incubated with MGC-803 cells, respectively, for 24 hFigure 5 Laser scanning confocal microscopy images
(3D mode) of MGC-803 cells.at 37°C. In control experiments, we select RNase A and
C-dots to carry out accordingly the same procedure and
keep equal contents of bare C-dots with RNase A@C-dot
solution. The results (Figure 6a) show clearly that RNase
A alone could restrain the cancerous cells due to the
ribonuclease-mediated toxicity [27]. Moreover, the ability
of RNase A in inhibiting the cancerous cells exhibits a
content-dependent character with a relatively low cell
viability (61%) at higher concentration (300 μg/ml) and
a high one at lower concentration (36.5 μg/ml). Noting
the fact that the bare C-dots demonstrate no cytotox-
icity (cell viability 92.7%) even at the highest concentra-
tion (3,000 μg/ml), we could conclude reasonably that
the low cell viability (68.5%) which resulted from C-dot
treated at the same concentration comes not from the
bare C-dots but from RNase A on the surface via its
ribonuclease-mediated toxicity. So, by MTT assay, we
have validated the potential of the RNase A@C-dots in
cancer therapy.
While MTT assay only gave the information of cytotox-
icity at fixed time points, the time-dependent cell response
profiling was performed using real-time cell electronic
sensing (RT-CES). Without cell labeling, the RT-CES assay
directly reflected changes in cell biological status including
cell viability, cell number, morphology, and adhesion [36].
Briefly, increasing in cell adhesion or cell spread will result
in a larger cell/electrode contact area which is presented
by a larger cell index (CI) value, while on the other hand,
toxicity induced cells can round up leading to a smaller
CI [37]. In good accordance with the MTT, RNase A
(150 μg/ml) or RNase A@C-dots with the same RNase
A concentration (150 μg/ml) were used based on the
results of MTT assay. RNase A alone can inhibit and kill
cancerous cells with a final CI value very close to zero
Figure 6 Cytotoxicity assay results. (a) MTT assay determined cytotoxicity profile of RNase A, C-dots, and RNase A@C-dots after 24 h incubation
with MGC-803 cells at varied concentrations (sample size N = 3). (b) Dynamic monitoring cytotoxic response of MGC803 cells to RNase A, C-dots,
and RNase A@C-dots.
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ability in killing cancer cells with a CI value of around
0.2 compared to 1.8 of cells alone. In fact, RNase A and
C-dots featured some differences concerning their per-
formances. After adding of RNase A, the CI value in-
creased a little bit in the first 4 h and then decreased
continuously, while the adding of RNase A@C-dots
resulted in a nearly unchanged CI value until about 50 h
and then a decrease in CI value until the end. We sug-
gest that this might have resulted from the difference of
migration rate. In order to inhibit the cancerous cells,
RNase A must enter cells and mount to a certain
concentration. Suffering from a lower migration rate, it
takes more time for RNase A@C-dots to concentrate
into the cells compared to RNase A. As expected, RNase
A@C-dots could hardly be considered as toxic as the CI
value kept increasing at the beginning of nearly 50 h.
However, after 50 h, the CI value became lower than
that of the control group. This may be caused by the
concentration accumulative effect of RNase A@C-dots
in the cells which could have an impact over the status
of the cells within an acceptable range. So it is provenFigure 7 Representative in vivo fluorescence images of MGC-803 tum
after 10 min, 4 h and 12 h.that the RNase A@C-dots could kill cancerous cells with
its ribonuclease-mediated toxicity from surface-doped
RNase A, and not C-dots itself. However, the dose of the
RNase A or RNase A@C-dots is a key factor to have an
effect on the therapy, and the specific mechanism is still
unclear and further study is necessary.
RNase A@C-dots for in vivo imaging of gastric cancer
As shown in Figure 7, obvious luminescence signal could
be observed in the tumor after intratumoral injection.
The RNase A@C-dots resulted in high contrast images
and could be easily distinguished from the background.
The luminescence intensity shows a clear time-dependent
characteristic. Twelve hours after injection, the lumines-
cence intensity had been dramatically decreased. This
could probably be explained by the ability of carbon dots
to pass the glomerulus and be excreted by urine [38].
Conclusions
In summary, we have synthesized the multifunctional
RNase A@C-dots particles by one-step microwave method
using the biological molecule of RNase A as an assistantor-bearing mouse. After intratumoral injection with RNase A@C-dots
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escence intensity in contrast to bare C-dots. The quantum
yield is nearly 30 times higher reaching 24.20% instead of
0.87% with a narrow Stokes shift only of approximately
80 nm. The RNase A@C-dots could not only penetrate
the cell membrane but can also enter the nuclei of cells
efficiently. Moreover, the RNase A@C-dots also show
potential ability in inhibiting and killing cancer cells.
Hopefully, the RNase A@C-dots could be used in nano-
diagnostics and nanotherapeutics in the feature. But
before that, the detailed mechanism which still remains
vague behind the interactions between the C-dots and
cancer cells should be fully understood.
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